Evidence map›Paper›PMID 42645369›Full record

ArticleCurrent oncology (Toronto, Ont.)2026

A Parsimonious Ultrasound Radiomics and Ki-67 Model for Estimating MammaPrint Risk Categorization in HR+/HER2- Early Breast Cancer.

Yuanjing Gao, Yanwen Luo, Zihan Niu, Mengyuan Zhou, Mengsu Xiao, Tianjiao Chen, Jia Lu, Yuxin Jiang, Bo Pan, Qingli Zhu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current oncology (Toronto, Ont.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yuanjing GaoDepartment of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China.
Yanwen LuoDepartment of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Zihan NiuDepartment of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China.
Mengyuan ZhouDepartment of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China.
Mengsu XiaoDepartment of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China.
Tianjiao ChenDepartment of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China.
Jia LuDepartment of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China.
Yuxin JiangDepartment of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China.
Bo PanDepartment of Breast Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China.
Qingli ZhuDepartment of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China.ORCID 0000-0002-0618-2381

Funding

Chinese Academy of Medical Sciences & Peking Union Medical College 2024-I2M-C&T-B-035National Health Commission 2025-PUMCH-A-015Peking Union Medical College Hospital No.UBJ10852
6 · The paper itself

Abstract

The 70-gene signature (70-GS; MammaPrint) assay is useful for prognosis assessment in HR+/HER2- early breast cancer, but limited accessibility motivates development of noninvasive alternatives. We retrospectively enrolled 219 women with preoperative grayscale ultrasound and 70-GS results, including a development cohort (

Indexed as

Breast NeoplasmsKi-67 AntigenErb-b2 Receptor Tyrosine KinasesFemaleHumansMiddle AgedRadiomicsReceptors, ProgesteroneRetrospective StudiesUltrasonographyERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesKi-67 AntigenReceptors, Progesterone70-gene signature (MammaPrint)breast cancernomogramprognosisradiomics

Identifiers

PMID42645369
PMCPMC13510384

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.